STERLING PHARMA SOLUTIONS LIMITED
STERLING PHARMA SOLUTIONS LIMITED is a Private limited company (Ltd.) registered in United Kingdom under 05712796, and its current status with Companies House is active. The company was incorporated on 16 February 2006 and lists its registered address as Cramlington, United Kingdom. 1 shareholder is on record for STERLING PHARMA SOLUTIONS LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of STERLING PHARMA SOLUTIONS LIMITED
One shareholder is currently on record for STERLING PHARMA SOLUTIONS LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is SAFFRON BIDCO LIMITED, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| SAFFRON BIDCO LIMITED | 100% | Companies House |
Officers
28
Directors and officers of STERLING PHARMA SOLUTIONS LIMITED
Two of the 28 officer records shown for STERLING PHARMA SOLUTIONS LIMITED are current appointments, filed with Companies House. Karl Rotthier (appointed 2025-11-03) and Septima Maguire (appointed 2026-05-05) both serve as Director. The remaining 26 records shown (Qa Nominees Limited, Jagdish Nanchand Sheth and 22 others) are former appointments that have since been resigned. Management authority at STERLING PHARMA SOLUTIONS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of STERLING PHARMA SOLUTIONS LIMITED
STERLING PHARMA SOLUTIONS LIMITED sits 6 levels below its ultimate parent, VANQUISH TOPCO (JERSEY) LIMITED, registered in United Kingdom. 6 subsidiaries are recorded beneath it, across 3 jurisdictions. Immediately above STERLING PHARMA SOLUTIONS LIMITED is SAFFRON BIDCO LIMITED, holding 100% as filed in STERLING PHARMA SOLUTIONS LIMITED's own shareholder record with Companies House. VANQUISH TOPCO (JERSEY) LIMITED sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- STERLING BIDCO IRELAND LIMITED (Ireland)
- Sterling Wisconsin, LLC (United States)
- STERLING NEWCASTLE LIMITED (United Kingdom)
- STERLING DEESIDE LIMITED (United Kingdom)
- Sterling Pharma Usa, LLC (United States)
- SAFFRON NEWCO LIMITED (United Kingdom)
Data availability
Those 6 subsidiaries span United Kingdom, Ireland, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 6 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
VANQUISH TOPCO (JERSEY) LIMITED
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns STERLING PHARMA SOLUTIONS LIMITED?
One shareholder is currently on record for STERLING PHARMA SOLUTIONS LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is SAFFRON BIDCO LIMITED, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is STERLING PHARMA SOLUTIONS LIMITED's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for STERLING PHARMA SOLUTIONS LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does STERLING PHARMA SOLUTIONS LIMITED have on record?
1 shareholder is shown on record for STERLING PHARMA SOLUTIONS LIMITED.
What is STERLING PHARMA SOLUTIONS LIMITED's company registration number?
STERLING PHARMA SOLUTIONS LIMITED's registration number is 05712796, filed with Companies House in United Kingdom. Its current status on the register is active.
Is STERLING PHARMA SOLUTIONS LIMITED still an active company?
STERLING PHARMA SOLUTIONS LIMITED's status on Companies House is listed as active.
When was STERLING PHARMA SOLUTIONS LIMITED incorporated?
STERLING PHARMA SOLUTIONS LIMITED was incorporated on 16 February 2006, according to Companies House.
What is STERLING PHARMA SOLUTIONS LIMITED's registered address?
The registered address on file for STERLING PHARMA SOLUTIONS LIMITED is Cramlington, United Kingdom.
What legal structure is STERLING PHARMA SOLUTIONS LIMITED registered as?
STERLING PHARMA SOLUTIONS LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of STERLING PHARMA SOLUTIONS LIMITED?
Two of the 28 officer records shown for STERLING PHARMA SOLUTIONS LIMITED are current appointments, filed with Companies House. Karl Rotthier (appointed 2025-11-03) and Septima Maguire (appointed 2026-05-05) both serve as Director. The remaining 26 records shown (Qa Nominees Limited, Jagdish Nanchand Sheth and 22 others) are former appointments that have since been resigned. Management authority at STERLING PHARMA SOLUTIONS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does STERLING PHARMA SOLUTIONS LIMITED have a parent company or subsidiaries?
STERLING PHARMA SOLUTIONS LIMITED sits 6 levels below its ultimate parent, VANQUISH TOPCO (JERSEY) LIMITED, registered in United Kingdom. 6 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 6 subsidiaries span United Kingdom, Ireland, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 6 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to STERLING PHARMA SOLUTIONS LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to STERLING PHARMA SOLUTIONS LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access STERLING PHARMA SOLUTIONS LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like STERLING PHARMA SOLUTIONS LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 25 September 2026.